Physician
Prospect Chartercare RWMC, LLC
Prospect Chartercare RWMC, LLC was paid $2.38M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoPROSPECT CHARTERCARE RWMC, LLC
PROVIDENCE, RI 02908
PROVIDENCE, RI 02908
33aNPI1285059287assigned 02/27/2014
33bProvider typeAddiction Medicine (Internal Medicine) Physician
28Total paid$2.38M
24GClaims54,829
24DCodes billed101
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Addiction Medicine (Internal Medicine) Physician providers in Rhode Island
Rank by total paid#2 of 8
Median peer was paid$64K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,717 | $783K | |
| 2019 | 10,407 | $429K | |
| 2020 | 9,217 | $410K | |
| 2021 | 5,370 | $211K | |
| 2022 | 2,131 | $105K | |
| 2023 | 4,013 | $253K | |
| 2024incomplete | 2,974 | $191K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 1,973 | 1,596 | $496K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.9% | 4,534 | 3,631 | $236K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7.4% | 665 | 248 | $176K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 7.1% | 1,916 | 1,722 | $169K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 5.7% | 6,680 | 2,338 | $136K |
| 99223 | Prolong inpt eval add15 m | 5.5% | 1,475 | 1,398 | $130K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.6% | 2,534 | 1,940 | $110K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.7% | 862 | 307 | $65K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.7% | 860 | 314 | $63K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 378 | 302 | $61K |
| 99239 | Hospital discharge day management, more than 30 minutes | 2.3% | 1,234 | 1,177 | $54K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 362 | 188 | $44K |
89 more codes
| 80053 | Comprehensive metabolic panel | 1.8% | 2,711 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 3,958 | $43K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.7% | 893 | $41K |
| 99285 | Emergency room visit (most serious) | 1.5% | 166 | $37K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.5% | 94 | $37K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 1,388 | $35K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.3% | 203 | $31K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 442 | $29K |
| 80061 | Lipid panel | 1.2% | 1,339 | $28K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 254 | $20K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 282 | $16K |
| 82607 | <1% | 699 | $16K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 157 | $16K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 397 | $16K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,150 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,522 | $15K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 397 | $14K |
| 86141 | <1% | 675 | $13K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 83 | $12K |
| 82728 | <1% | 566 | $12K | |
| 80305 | <1% | 763 | $11K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 129 | $11K |
| 85027 | <1% | 1,020 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 157 | $9K |
| 84439 | <1% | 495 | $7K | |
| 83540 | <1% | 598 | $6K | |
| 99284 | Emergency room visit (serious) | <1% | 82 | $6K |
| 85610 | <1% | 1,031 | $6K | |
| 80076 | <1% | 521 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 86 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 86 | $5K |
| 84466 | <1% | 257 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 307 | $4K |
| 94726 | <1% | 74 | $4K | |
| 84460 | <1% | 485 | $4K | |
| 94729 | <1% | 72 | $4K | |
| 84450 | <1% | 474 | $4K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 35 | $4K |
| 82565 | <1% | 479 | $3K | |
| 81001 | <1% | 816 | $3K | |
| 82746 | <1% | 212 | $3K | |
| 85652 | <1% | 768 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 26 | $3K |
| 86803 | <1% | 133 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 22 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 334 | $2K |
| 84100 | <1% | 341 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 86 | $2K |
| 83735 | <1% | 195 | $2K | |
| 90785 | <1% | 398 | $2K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 249 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 202 | $1K |
| 94060 | <1% | 20 | $1K | |
| 85045 | <1% | 179 | $993.32 | |
| 96415 | <1% | 15 | $971.52 | |
| 84207 | <1% | 23 | $715.19 | |
| 82043 | <1% | 89 | $673.01 | |
| 82550 | <1% | 77 | $568.52 | |
| 86850 | <1% | 78 | $529.17 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 99 | $426.60 |
| 84154 | <1% | 13 | $404.43 | |
| 84480 | <1% | 22 | $386.46 | |
| 86900 | <1% | 86 | $374.18 | |
| 86901 | <1% | 86 | $369.80 | |
| 87340 | <1% | 19 | $282.96 | |
| 84520 | <1% | 59 | $280.51 | |
| 84425 | <1% | 29 | $264.91 | |
| 85730 | <1% | 32 | $254.44 | |
| 88342 | <1% | 12 | $246.87 | |
| 82040 | <1% | 42 | $204.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 216 | $174.56 |
| 82947 | <1% | 35 | $148.86 | |
| 84550 | <1% | 23 | $143.64 | |
| 87081 | <1% | 60 | $91.56 | |
| 87186 | <1% | 26 | $78.36 | |
| 81025 | <1% | 68 | $77.98 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 332 | $66.45 |
| 84484 | <1% | 70 | $58.54 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 376 | $38.43 |
| 99221 | <1% | 31 | $38.18 | |
| 99307 | <1% | 87 | $18.58 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 97 | $12.50 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 168 | $7.04 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 177 | $6.88 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 39 | $1.82 |
| 82962 | 0% | 76 | $0.00 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 39 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 52 | $0.00 |
| 99238 | Hospital discharge day management, 30 minutes or less | 0% | 95 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSABILLO, ALFREDO (SENIOR VICE PRESIDENT)